SBC Medical Group (NASDAQ:SBC - Get Free Report) is anticipated to announce its earnings results before the market opens on Wednesday, March 12th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $56.34 million for the quarter.
SBC Medical Group Stock Performance
SBC traded down $0.04 during trading on Thursday, reaching $3.26. 16,287 shares of the company were exchanged, compared to its average volume of 62,271. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.76 and a current ratio of 2.79. SBC Medical Group has a 12-month low of $2.62 and a 12-month high of $12.50. The company has a 50-day simple moving average of $4.84.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Recommended Stories
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
